Skip to main content

Animations

MJFF Publications

6071 - 6080 of 8785 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2024
  • 2024
  • 2020
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: LRRK2 kinase activity regulates Parkinson’s disease-relevant lipids at the lysosome
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-025-00880-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Language impairment is associated with faster progression in progressive supranuclear palsy‐Richardson syndrome
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.70485
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Supplemental ambient lighting intervention to improve sleep in Parkinson's disease: A pilot trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107149
    Citation Count: 3
  • Summary Details
    OPEN
    Title: ModFus-PD: synergizing cross-modal attention and contrastive learning for enhanced multimodal diagnosis of Parkinson’s disease
    Journal Name: Frontiers in Computational Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncom.2025.1604399
    Citation Count: 0
  • Summary Details
    OPEN
    Title: SAGEFusionNet: An Auxiliary Supervised Graph Neural Network for Brain Age Prediction as a Neurodegenerative Biomarker
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci15070752
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Concerns with the new biological research criteria for synucleinopathy
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00213-8
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Expanding the phenotype of PPP1R21‐related neurodevelopmental disorder
    Journal Name: Clinical Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/cge.14492
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer’s Disease (4738)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4738
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Longitudinal analysis of step counts in Parkinson’s disease patients: insights from a web-based application and generalized additive model
    Journal Name: PeerJ
    Publisher: PeerJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7717/peerj.19519
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00588
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.